Compare TTK HEALTHCARE with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AUROBINDO PHARMA TTK HEALTHCARE/
AUROBINDO PHARMA
 
P/E (TTM) x 17.3 11.0 157.4% View Chart
P/BV x 1.4 2.4 58.0% View Chart
Dividend Yield % 1.1 0.5 212.6%  

Financials

 TTK HEALTHCARE   AUROBINDO PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
AUROBINDO PHARMA
Mar-18
TTK HEALTHCARE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,215809 150.2%   
Low Rs610504 121.1%   
Sales per share (Unadj.) Rs444.4281.1 158.1%  
Earnings per share (Unadj.) Rs17.241.4 41.7%  
Cash flow per share (Unadj.) Rs27.650.9 54.3%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Dividend yield (eoy) %0.50.4 143.9%  
Book value per share (Unadj.) Rs177.9199.4 89.3%  
Shares outstanding (eoy) m14.13585.88 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.3 87.9%   
Avg P/E ratio x52.915.9 333.3%  
P/CF ratio (eoy) x33.012.9 256.0%  
Price / Book Value ratio x5.13.3 155.7%  
Dividend payout %29.06.0 479.6%   
Avg Mkt Cap Rs m12,894384,630 3.4%   
No. of employees `0002.317.3 13.3%   
Total wages/salary Rs m1,30721,308 6.1%   
Avg. sales/employee Rs Th2,715.79,500.7 28.6%   
Avg. wages/employee Rs Th565.31,229.4 46.0%   
Avg. net profit/employee Rs Th105.41,397.9 7.5%   
INCOME DATA
Net Sales Rs m6,279164,666 3.8%  
Other income Rs m781,020 7.6%   
Total revenues Rs m6,356165,686 3.8%   
Gross profit Rs m49637,718 1.3%  
Depreciation Rs m1475,580 2.6%   
Interest Rs m34777 4.3%   
Profit before tax Rs m39332,380 1.2%   
Minority Interest Rs m031 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1498,183 1.8%   
Profit after tax Rs m24424,229 1.0%  
Gross profit margin %7.922.9 34.5%  
Effective tax rate %37.925.3 150.1%   
Net profit margin %3.914.7 26.4%  
BALANCE SHEET DATA
Current assets Rs m2,717121,878 2.2%   
Current liabilities Rs m1,57186,806 1.8%   
Net working cap to sales %18.321.3 85.7%  
Current ratio x1.71.4 123.2%  
Inventory Days Days32130 24.8%  
Debtors Days Days4768 68.2%  
Net fixed assets Rs m99181,037 1.2%   
Share capital Rs m141586 24.1%   
"Free" reserves Rs m2,373116,218 2.0%   
Net worth Rs m2,514116,804 2.2%   
Long term debt Rs m34,512 0.1%   
Total assets Rs m4,158211,052 2.0%  
Interest coverage x12.642.7 29.6%   
Debt to equity ratio x00 3.5%  
Sales to assets ratio x1.50.8 193.5%   
Return on assets %6.711.8 56.3%  
Return on equity %9.720.7 46.7%  
Return on capital %16.927.4 61.9%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22580,727 0.3%   
Fx outflow Rs m7134,700 0.2%   
Net fx Rs m15446,027 0.3%   
CASH FLOW
From Operations Rs m17319,548 0.9%  
From Investments Rs m97-19,570 -0.5%  
From Financial Activity Rs m-3078,642 -3.6%  
Net Cashflow Rs m-388,922 -0.4%  

Share Holding

Indian Promoters % 65.4 54.1 120.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 8.0 46.5%  
FIIs % 5.2 27.7 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.2 252.9%  
Shareholders   12,723 69,601 18.3%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PROCTER & GAMBLE HEALTH  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Oct 18, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - SUVEN LIFESCIENCES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS